Abstract CT094: Novel treatment with intraperitoneal MOC31PE immunotoxin in colorectal peritoneal metastasis: Long-term outcome from the ImmunoPeCa phase I/II trial

2018 ◽  
Author(s):  
Ida S. Froysnes ◽  
Yvonne Andersson ◽  
Stein Larsen ◽  
Ben Davidson ◽  
Janne-Merete T. Oien ◽  
...  
Keyword(s):  
Phase I ◽  
Peritoneal Metastasis ◽  
Term Outcome ◽  
Long Term Outcome ◽  
Novel Treatment

scholarly journals Somatostatin-based radiotherapy with [90Y-DOTA]-TOC in neuroendocrine tumors: long-term outcome of a phase I dose escalation study

2013 ◽  
Vol 11 (1) ◽  
pp. 17 ◽  
Author(s):  
Nicolas Marincek ◽  
Ann-Catherine Jörg ◽  
Philippe Brunner ◽  
Christian Schindler ◽  
Michael T Koller ◽  
...  
Keyword(s):  
Phase I ◽  
Neuroendocrine Tumors ◽  
Dose Escalation ◽  
Dose Escalation Study ◽  
Term Outcome ◽  
Long Term Outcome

Long-Term Outcome of Phase I/II Clinical Trial of Ad-OC-TK/VAL Gene Therapy for Hormone-Refractory Metastatic Prostate Cancer

2007 ◽  
Vol 18 (12) ◽  
pp. 1225-1232 ◽  
Author(s):  
Toshiro Shirakawa ◽  
Shuji Terao ◽  
Nobuyuki Hinata ◽  
Kazushi Tanaka ◽  
Atsushi Takenaka ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Clinical Trial ◽  
Gene Therapy ◽  
Phase I ◽  
Metastatic Prostate Cancer ◽  
Term Outcome ◽  
Long Term Outcome ◽  
Hormone Refractory

scholarly journals ImmunoPeCa trial: Long-term outcome following intraperitoneal MOC31PE immunotoxin treatment in colorectal peritoneal metastasis

2021 ◽  
Vol 47 (1) ◽  
pp. 134-138 ◽  
Author(s):  
Ida S. Frøysnes ◽  
Yvonne Andersson ◽  
Stein G. Larsen ◽  
Ben Davidson ◽  
Janne-Merete Torset Øien ◽  
...  
Keyword(s):  
Peritoneal Metastasis ◽  
Term Outcome ◽  
Long Term Outcome

Long-term outcome and toxicity in a Phase I/II trial using HDR multicatheter interstitial brachytherapy for T1-2 breast cancer

Brachytherapy ◽  
2006 ◽  
Vol 5 (2) ◽  
pp. 86 ◽  
Author(s):  
Seth A. Kaufman ◽  
Thomas A. DiPetrillo ◽  
Jennifer Bassett Midle ◽  
Lori Lyn Price ◽  
David E. Wazer
Keyword(s):  
Breast Cancer ◽  
Phase I ◽  
Interstitial Brachytherapy ◽  
Term Outcome ◽  
Long Term Outcome

Long-term outcome and toxicity in a Phase I/II trial using high-dose-rate multicatheter interstitial brachytherapy for T1/T2 breast cancer

Brachytherapy ◽  
2007 ◽  
Vol 6 (4) ◽  
pp. 286-292 ◽  
Author(s):  
Seth A. Kaufman ◽  
Thomas A. DiPetrillo ◽  
Lori Lyn Price ◽  
Jennifer Bassett Midle ◽  
David E. Wazer
Keyword(s):  
Breast Cancer ◽  
Phase I ◽  
Dose Rate ◽  
High Dose Rate ◽  
Interstitial Brachytherapy ◽  
High Dose ◽  
Term Outcome ◽  
Long Term Outcome

scholarly journals Long-term outcome of phase I/II prospective study of dose-escalated proton therapy for early-stage non-small cell lung cancer

2017 ◽  
Vol 122 (2) ◽  
pp. 274-280 ◽  
Author(s):  
Joe Y. Chang ◽  
Wencheng Zhang ◽  
Ritsuko Komaki ◽  
Noah C. Choi ◽  
Shen Chan ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Prospective Study ◽  
Phase I ◽  
Proton Therapy ◽  
Early Stage ◽  
Small Cell ◽  
Small Cell Lung ◽  
Term Outcome ◽  
Long Term Outcome

scholarly journals Results from Phase I Clinical Trial with Intraspinal Injection of Neural Stem Cells in Amyotrophic Lateral Sclerosis: A Long‐Term Outcome

2019 ◽  
Vol 8 (9) ◽  
pp. 887-897 ◽  
Author(s):  
Letizia Mazzini ◽  
Maurizio Gelati ◽  
Daniela Celeste Profico ◽  
Gianni Sorarù ◽  
Daniela Ferrari ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Stem Cells ◽  
Amyotrophic Lateral Sclerosis ◽  
Neural Stem Cells ◽  
Phase I ◽  
Term Outcome ◽  
Long Term Outcome ◽  
Lateral Sclerosis ◽  
Intraspinal Injection
Sign in / Sign up

Export Citation Format

Share Document